articleInternational Journal of OncologyFeb 29, 2024HYBRID OA

Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)

Dalian Medical University · Second Affiliated Hospital of Dalian Medical University

PubMed
Indexed incrossrefpubmed

Abstract

Cancer is one of the leading causes of mortality worldwide. The etiology of cancer has not been fully elucidated yet, and further enhancements are necessary to optimize therapeutic efficacy. Butyrate, a short‑chain fatty acid, is generated through gut microbial fermentation of dietary fiber. Studies have unveiled the relevance of butyrate in malignant neoplasms, and a comprehensive understanding of its role in cancer is imperative for realizing its full potential in oncological treatment. Its full antineoplastic effects via the activation of G protein‑coupled receptors and the inhibition of histone deacetylases have been also confirmed. However, the underlying mechanistic details remain unclear. The present…

No related works found for this paper.

Funding